000915.SZ · 华特达因
China A-shares · RS rating 40 · As of 2026-10-14
| Price | 24.81 CNY |
|---|---|
| 1-day change | +2.7% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 56 / 55 / 37 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 22 / 6 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.8% |
| Distance from 52-week high | +30.3% |
| Market cap (USD) | $848.8M |